Zynx Health Ranked #1 for Clinical Decision Support

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: March 26, 2023

Atlanta Housing, Residents Celebrate 102nd Birthday of Clara "Mama" Bridges • SOTERA HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Los • Dr. Kelli Ward and Martha Boneta Fain join the advisory board of Legacy PAC, a partner of Veterans for Trump • Jennifer S. Wilkov Finalizes Lineup for the 2023 April Speak Up Women Conference • SAMARITAN'S PURSE RUSHING HELP TO FAMILIES IMPACTED BY DEADLY TORNADOES IN MISSISSIPPI • National University Receives 2023 Military Friendly® Gold Designation • Early Education Leadership Conference in Hershey Brings Together Hundreds of Child Advocates • Here Comes Bunnysaurus Rex Hopping Down the Dinosaur Trail • SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Stanley Black & Decker, Inc. with Losses of $100,000 t • HYZON MOTORS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers • Statement from the Chief Public Health Officer of Canada on World TB Day • SOTERA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sote • Philadelphia Works Names First Female Chief Operating Officer • AI-Powered Stylitics Launches Latest Platform with First-of-Its-Kind Automated Styling Technology for Retailers • Build community with shared future, create better world • DISH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DISH Network Corporatio • GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Office • 30+ Health Leaders Explore Strategies to Ease Hospital-to-Home Patient Transitions • ImmunoGen Presents Final Overall Survival and Additional Efficacy Data from the SORAYA Trial at SGO Annual Meeting • ARGO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Argo B

Zynx Health Ranked #1 for Clinical Decision Support – Care Plans and Order Sets in KLAS Research’s 2023 Best in KLAS

LOS ANGELES , February 09 /Businesswire/ - Zynx Health, a pioneer and market leader in evidence- and experience-based clinical solutions, has been ranked #1 in KLAS Research’s 2023 Best in KLAS Awards in the category of Clinical Decision Support – Care Plans and Order Sets.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230209005267/en/

Zynx Health is the KLAS Research 2023 Best in KLAS recipient for Clinical Decision Support: Care Plans & Order Sets (Graphic: Business Wire)

The designation marks the third consecutive year in which Zynx Health’s solutions have been awarded top honors by KLAS Research, and its seventh Best in KLAS designation overall. Zynx received near-perfect scores across the grading criteria (Culture, Loyalty, Operations, Product, Relationship, Value) used to assess Best in KLAS status.

“The 2023 Best in KLAS report highlights the top-performing healthcare IT solutions as determined by extensive evaluations and conversations with thousands of healthcare providers,” said Adam Gale, KLAS CEO. “These distinguished winners have demonstrated exceptional dedication to improving and innovating the industry, and their efforts are recognized through their inclusion in this report. Congratulations to all the winning vendors for setting the bar for excellence in healthcare IT! KLAS continues to be committed to creating transparency and helping providers make informed decisions through our accurate, honest, and impartial reporting.”

“We have tremendous respect for the service KLAS Research performs in helping hospitals and healthcare organizations make informed decisions in selecting a clinical decision support solution for their organizations,” said Chuck Tuchinda, MD, president of Zynx Health. “For more than 25 years, our mission has been to help organizations measurably improve the quality, safety, and efficiency of patient care in a way that benefits all. We view this ranking as a reflection of our success driving toward this mission because it is determined by the value our clients derive from Zynx solutions. It’s an honor to be recognized for the third consecutive year. We are grateful for the opportunity to help improve the practice of medicine with the highest quality evidence-based care guidance on the market.”

About Zynx Health

Founded in 1996, Zynx Health is a pioneer and market leader in evidence- and experience-based clinical solutions that help health systems improve patient outcomes, financial outcomes, clinical engagement, and technology performance. Part of the Hearst Health network, Zynx Health helps healthcare organizations exceed industry demands for delivering high-quality, standardized care at lower costs under value-based reimbursement models. To learn more, visit zynxhealth.com or call 888.996.9435. Follow Zynx Health on LinkedIn @Zynx-Health.

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85% of discharged patients, 205 million insured individuals, 103 million home health visits, and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

About KLAS Research

KLAS has been providing accurate, honest, and impartial insights for the healthcare IT (HIT) industry since 1996. The KLAS mission is to improve the world’s healthcare by amplifying the voice of providers and payers. The scope of our research is constantly expanding to best fit market needs as technology becomes increasingly sophisticated. KLAS finds the hard-to-get HIT data by building strong relationships with our payer and provider friends in the industry. To learn more about KLAS, visit KLASresearch.com.